Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2. - Gnant M; Baselga J; Rugo HS; Noguchi S; Burris HA; Piccart M; Hortobagyi GN; Eakle J; Mukai H; Iwata H; Geberth M; Hart LL; et al. (Journal of the National Cancer Institute, 2013)